Fertilization: Conventional IVF versus ICSI

Karla Saner Amigh

doi:10.1007/978-3-030-23235-1_18

Fertilization: Conventional IVF versus ICSI

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Intracytoplasmic sperm injection (ICSI) was developed in humans in the early 1990s as a mechanism to overcome complete fertilization failure due to severe male factor infertility. ICSI can be used with motile, nonmotile, ejaculated, or surgically retrieved testicular sperm to produce a viable embryo resulting in live birth. As the safety and efficacy of ICSI were demonstrated, its use became more widespread. ICSI has been applied to other infertility-related issues such as unexplained infertility, use with frozen gametes, serodiscordant couples, and patients with diminished ovarian reserve and/or advanced reproductive age, in addition to male factor infertility. While, in general, ICSI use may not show a major disadvantage over conventional insemination, the insemination method should be a carefully considered option based on individual patient needs.

Original language	English (US)
Title of host publication	Diminished Ovarian Reserve and Assisted Reproductive Technologies
Subtitle of host publication	Current Research and Clinical Management
Publisher	Springer International Publishing
Pages	221-230
Number of pages	10
ISBN (Electronic)	9783030232351
ISBN (Print)	9783030232344
DOIs	https://doi.org/10.1007/978-3-030-23235-1_18
State	Published - Jan 1 2019

Keywords

ICSI
In vitro fertilization
Intracytoplasmic sperm injection

ASJC Scopus subject areas

Health Professions(all)
Medicine(all)

Access to Document

10.1007/978-3-030-23235-1_18

Cite this

@inbook{19d77707b7dd40c69145d90302f9102e,

title = "Fertilization: Conventional IVF versus ICSI",

abstract = "Intracytoplasmic sperm injection (ICSI) was developed in humans in the early 1990s as a mechanism to overcome complete fertilization failure due to severe male factor infertility. ICSI can be used with motile, nonmotile, ejaculated, or surgically retrieved testicular sperm to produce a viable embryo resulting in live birth. As the safety and efficacy of ICSI were demonstrated, its use became more widespread. ICSI has been applied to other infertility-related issues such as unexplained infertility, use with frozen gametes, serodiscordant couples, and patients with diminished ovarian reserve and/or advanced reproductive age, in addition to male factor infertility. While, in general, ICSI use may not show a major disadvantage over conventional insemination, the insemination method should be a carefully considered option based on individual patient needs.",

keywords = "ICSI, In vitro fertilization, Intracytoplasmic sperm injection",

author = "Amigh, {Karla Saner}",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-23235-1_18",

language = "English (US)",

isbn = "9783030232344",

pages = "221--230",

booktitle = "Diminished Ovarian Reserve and Assisted Reproductive Technologies",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Fertilization

T2 - Conventional IVF versus ICSI

AU - Amigh, Karla Saner

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Intracytoplasmic sperm injection (ICSI) was developed in humans in the early 1990s as a mechanism to overcome complete fertilization failure due to severe male factor infertility. ICSI can be used with motile, nonmotile, ejaculated, or surgically retrieved testicular sperm to produce a viable embryo resulting in live birth. As the safety and efficacy of ICSI were demonstrated, its use became more widespread. ICSI has been applied to other infertility-related issues such as unexplained infertility, use with frozen gametes, serodiscordant couples, and patients with diminished ovarian reserve and/or advanced reproductive age, in addition to male factor infertility. While, in general, ICSI use may not show a major disadvantage over conventional insemination, the insemination method should be a carefully considered option based on individual patient needs.

AB - Intracytoplasmic sperm injection (ICSI) was developed in humans in the early 1990s as a mechanism to overcome complete fertilization failure due to severe male factor infertility. ICSI can be used with motile, nonmotile, ejaculated, or surgically retrieved testicular sperm to produce a viable embryo resulting in live birth. As the safety and efficacy of ICSI were demonstrated, its use became more widespread. ICSI has been applied to other infertility-related issues such as unexplained infertility, use with frozen gametes, serodiscordant couples, and patients with diminished ovarian reserve and/or advanced reproductive age, in addition to male factor infertility. While, in general, ICSI use may not show a major disadvantage over conventional insemination, the insemination method should be a carefully considered option based on individual patient needs.

KW - ICSI

KW - In vitro fertilization

KW - Intracytoplasmic sperm injection

UR - http://www.scopus.com/inward/record.url?scp=85085790743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085790743&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-23235-1_18

DO - 10.1007/978-3-030-23235-1_18

M3 - Chapter

AN - SCOPUS:85085790743

SN - 9783030232344

SP - 221

EP - 230

BT - Diminished Ovarian Reserve and Assisted Reproductive Technologies

PB - Springer International Publishing

ER -

Fertilization: Conventional IVF versus ICSI

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this